+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Dynavax Technologies Corporation - logo

Dynavax is a clinical-stage biopharmaceutical company with multiple product candidates in development for the treatment of autoimmune and inflammatory diseases, and the treatment of cancer. The company’s lead product candidates include HEPLISAV-B, an investigational adult hepatitis B vaccine; and AZD1419, which is in Phase II clinical trial for the treatment of asthma. Dynavax Technologies Corporation was founded in 1996 and is headquartered in Berkeley, California.

Angina Pectoris Drugs Global Market Report 2024 - Product Thumbnail Image

Angina Pectoris Drugs Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
From
Global Hepatitis B Vaccines Market 2020-2024 - Product Thumbnail Image

Global Hepatitis B Vaccines Market 2020-2024

  • Report
  • October 2020
  • 120 Pages
  • Global
From
Anthrax (Infectious Disease) - Drugs in Development, 2021 - Product Thumbnail Image

Anthrax (Infectious Disease) - Drugs in Development, 2021

  • Drug Pipelines
  • March 2021
  • Global
From
Diphtheria Global Market Report 2024 - Product Thumbnail Image

Diphtheria Global Market Report 2024

  • Report
  • January 2024
  • 175 Pages
  • Global
From
Herpes Zoster - Pipeline Insight, 2024 - Product Thumbnail Image

Herpes Zoster - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 85 Pages
  • Global
From
Pancreatitis - Pipeline Insight, 2024 - Product Thumbnail Image

Pancreatitis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
NK Cell therapies - Pipeline Insight, 2024 - Product Thumbnail Image

NK Cell therapies - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 120 Pages
  • Global
From
Recurrent or Metastatic Head and Neck cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Recurrent or Metastatic Head and Neck cancer - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 80 Pages
  • Global
From
Non-Small Cell Lung Cancer - Pipeline Review, H1 2020 - Product Thumbnail Image

Non-Small Cell Lung Cancer - Pipeline Review, H1 2020

  • Drug Pipelines
  • June 2020
  • 4664 Pages
  • Global
From
From
Asthma Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Asthma Therapeutics - Global Strategic Business Report

  • Report
  • May 2024
  • 194 Pages
  • Global
From
From
From
Loading Indicator